Copyright Reports & Markets. All rights reserved.

Global Oncology Clinical Trial Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Oncology Clinical Trial Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Prostate Cancer
    • 1.2.3 Lung Cancer
    • 1.2.4 Breast Cancer
    • 1.2.5 Leukemia
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Oncology Clinical Trial Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Lab
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Oncology Clinical Trial Market Perspective (2016-2027)
  • 2.2 Oncology Clinical Trial Growth Trends by Regions
    • 2.2.1 Oncology Clinical Trial Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Oncology Clinical Trial Historic Market Share by Regions (2016-2021)
    • 2.2.3 Oncology Clinical Trial Forecasted Market Size by Regions (2022-2027)
  • 2.3 Oncology Clinical Trial Industry Dynamic
    • 2.3.1 Oncology Clinical Trial Market Trends
    • 2.3.2 Oncology Clinical Trial Market Drivers
    • 2.3.3 Oncology Clinical Trial Market Challenges
    • 2.3.4 Oncology Clinical Trial Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Oncology Clinical Trial Players by Revenue
    • 3.1.1 Global Top Oncology Clinical Trial Players by Revenue (2016-2021)
    • 3.1.2 Global Oncology Clinical Trial Revenue Market Share by Players (2016-2021)
  • 3.2 Global Oncology Clinical Trial Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Oncology Clinical Trial Revenue
  • 3.4 Global Oncology Clinical Trial Market Concentration Ratio
    • 3.4.1 Global Oncology Clinical Trial Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Oncology Clinical Trial Revenue in 2020
  • 3.5 Oncology Clinical Trial Key Players Head office and Area Served
  • 3.6 Key Players Oncology Clinical Trial Product Solution and Service
  • 3.7 Date of Enter into Oncology Clinical Trial Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Clinical Trial Breakdown Data by Type

  • 4.1 Global Oncology Clinical Trial Historic Market Size by Type (2016-2021)
  • 4.2 Global Oncology Clinical Trial Forecasted Market Size by Type (2022-2027)

5 Oncology Clinical Trial Breakdown Data by Application

  • 5.1 Global Oncology Clinical Trial Historic Market Size by Application (2016-2021)
  • 5.2 Global Oncology Clinical Trial Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Oncology Clinical Trial Market Size (2016-2027)
  • 6.2 North America Oncology Clinical Trial Market Size by Type
    • 6.2.1 North America Oncology Clinical Trial Market Size by Type (2016-2021)
    • 6.2.2 North America Oncology Clinical Trial Market Size by Type (2022-2027)
    • 6.2.3 North America Oncology Clinical Trial Market Size by Type (2016-2027)
  • 6.3 North America Oncology Clinical Trial Market Size by Application
    • 6.3.1 North America Oncology Clinical Trial Market Size by Application (2016-2021)
    • 6.3.2 North America Oncology Clinical Trial Market Size by Application (2022-2027)
    • 6.3.3 North America Oncology Clinical Trial Market Size by Application (2016-2027)
  • 6.4 North America Oncology Clinical Trial Market Size by Country
    • 6.4.1 North America Oncology Clinical Trial Market Size by Country (2016-2021)
    • 6.4.2 North America Oncology Clinical Trial Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Oncology Clinical Trial Market Size (2016-2027)
  • 7.2 Europe Oncology Clinical Trial Market Size by Type
    • 7.2.1 Europe Oncology Clinical Trial Market Size by Type (2016-2021)
    • 7.2.2 Europe Oncology Clinical Trial Market Size by Type (2022-2027)
    • 7.2.3 Europe Oncology Clinical Trial Market Size by Type (2016-2027)
  • 7.3 Europe Oncology Clinical Trial Market Size by Application
    • 7.3.1 Europe Oncology Clinical Trial Market Size by Application (2016-2021)
    • 7.3.2 Europe Oncology Clinical Trial Market Size by Application (2022-2027)
    • 7.3.3 Europe Oncology Clinical Trial Market Size by Application (2016-2027)
  • 7.4 Europe Oncology Clinical Trial Market Size by Country
    • 7.4.1 Europe Oncology Clinical Trial Market Size by Country (2016-2021)
    • 7.4.2 Europe Oncology Clinical Trial Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Oncology Clinical Trial Market Size (2016-2027)
  • 8.2 Asia-Pacific Oncology Clinical Trial Market Size by Type
    • 8.2.1 Asia-Pacific Oncology Clinical Trial Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Oncology Clinical Trial Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Oncology Clinical Trial Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Oncology Clinical Trial Market Size by Application
    • 8.3.1 Asia-Pacific Oncology Clinical Trial Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Oncology Clinical Trial Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Oncology Clinical Trial Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Oncology Clinical Trial Market Size by Region
    • 8.4.1 Asia-Pacific Oncology Clinical Trial Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Oncology Clinical Trial Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Oncology Clinical Trial Market Size (2016-2027)
  • 9.2 Latin America Oncology Clinical Trial Market Size by Type
    • 9.2.1 Latin America Oncology Clinical Trial Market Size by Type (2016-2021)
    • 9.2.2 Latin America Oncology Clinical Trial Market Size by Type (2022-2027)
    • 9.2.3 Latin America Oncology Clinical Trial Market Size by Type (2016-2027)
  • 9.3 Latin America Oncology Clinical Trial Market Size by Application
    • 9.3.1 Latin America Oncology Clinical Trial Market Size by Application (2016-2021)
    • 9.3.2 Latin America Oncology Clinical Trial Market Size by Application (2022-2027)
    • 9.3.3 Latin America Oncology Clinical Trial Market Size by Application (2016-2027)
  • 9.4 Latin America Oncology Clinical Trial Market Size by Country
    • 9.4.1 Latin America Oncology Clinical Trial Market Size by Country (2016-2021)
    • 9.4.2 Latin America Oncology Clinical Trial Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Oncology Clinical Trial Market Size (2016-2027)
  • 10.2 Middle East & Africa Oncology Clinical Trial Market Size by Type
    • 10.2.1 Middle East & Africa Oncology Clinical Trial Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Oncology Clinical Trial Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Oncology Clinical Trial Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Oncology Clinical Trial Market Size by Application
    • 10.3.1 Middle East & Africa Oncology Clinical Trial Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Oncology Clinical Trial Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Oncology Clinical Trial Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Oncology Clinical Trial Market Size by Country
    • 10.4.1 Middle East & Africa Oncology Clinical Trial Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Oncology Clinical Trial Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 IQVIA
    • 11.1.1 IQVIA Company Details
    • 11.1.2 IQVIA Business Overview
    • 11.1.3 IQVIA Oncology Clinical Trial Introduction
    • 11.1.4 IQVIA Revenue in Oncology Clinical Trial Business (2016-2021)
    • 11.1.5 IQVIA Recent Development
  • 11.2 Charles River Laboratory
    • 11.2.1 Charles River Laboratory Company Details
    • 11.2.2 Charles River Laboratory Business Overview
    • 11.2.3 Charles River Laboratory Oncology Clinical Trial Introduction
    • 11.2.4 Charles River Laboratory Revenue in Oncology Clinical Trial Business (2016-2021)
    • 11.2.5 Charles River Laboratory Recent Development
  • 11.3 ICON Plc
    • 11.3.1 ICON Plc Company Details
    • 11.3.2 ICON Plc Business Overview
    • 11.3.3 ICON Plc Oncology Clinical Trial Introduction
    • 11.3.4 ICON Plc Revenue in Oncology Clinical Trial Business (2016-2021)
    • 11.3.5 ICON Plc Recent Development
  • 11.4 Medelis, Inc.
    • 11.4.1 Medelis, Inc. Company Details
    • 11.4.2 Medelis, Inc. Business Overview
    • 11.4.3 Medelis, Inc. Oncology Clinical Trial Introduction
    • 11.4.4 Medelis, Inc. Revenue in Oncology Clinical Trial Business (2016-2021)
    • 11.4.5 Medelis, Inc. Recent Development
  • 11.5 Medpace Holdings, Inc.
    • 11.5.1 Medpace Holdings, Inc. Company Details
    • 11.5.2 Medpace Holdings, Inc. Business Overview
    • 11.5.3 Medpace Holdings, Inc. Oncology Clinical Trial Introduction
    • 11.5.4 Medpace Holdings, Inc. Revenue in Oncology Clinical Trial Business (2016-2021)
    • 11.5.5 Medpace Holdings, Inc. Recent Development
  • 11.6 PAREXEL International
    • 11.6.1 PAREXEL International Company Details
    • 11.6.2 PAREXEL International Business Overview
    • 11.6.3 PAREXEL International Oncology Clinical Trial Introduction
    • 11.6.4 PAREXEL International Revenue in Oncology Clinical Trial Business (2016-2021)
    • 11.6.5 PAREXEL International Recent Development
  • 11.7 Pharmaceutical Product Development, LLC
    • 11.7.1 Pharmaceutical Product Development, LLC Company Details
    • 11.7.2 Pharmaceutical Product Development, LLC Business Overview
    • 11.7.3 Pharmaceutical Product Development, LLC Oncology Clinical Trial Introduction
    • 11.7.4 Pharmaceutical Product Development, LLC Revenue in Oncology Clinical Trial Business (2016-2021)
    • 11.7.5 Pharmaceutical Product Development, LLC Recent Development
  • 11.8 Pivotal
    • 11.8.1 Pivotal Company Details
    • 11.8.2 Pivotal Business Overview
    • 11.8.3 Pivotal Oncology Clinical Trial Introduction
    • 11.8.4 Pivotal Revenue in Oncology Clinical Trial Business (2016-2021)
    • 11.8.5 Pivotal Recent Development
  • 11.9 PRA Health Sciences
    • 11.9.1 PRA Health Sciences Company Details
    • 11.9.2 PRA Health Sciences Business Overview
    • 11.9.3 PRA Health Sciences Oncology Clinical Trial Introduction
    • 11.9.4 PRA Health Sciences Revenue in Oncology Clinical Trial Business (2016-2021)
    • 11.9.5 PRA Health Sciences Recent Development
  • 11.10 Syneos Health
    • 11.10.1 Syneos Health Company Details
    • 11.10.2 Syneos Health Business Overview
    • 11.10.3 Syneos Health Oncology Clinical Trial Introduction
    • 11.10.4 Syneos Health Revenue in Oncology Clinical Trial Business (2016-2021)
    • 11.10.5 Syneos Health Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Oncology Clinical Trial Scope and Market Size
    Oncology Clinical Trial market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Clinical Trial market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Prostate Cancer
    Lung Cancer
    Breast Cancer
    Leukemia
    Others

    Segment by Application
    Hospital
    Clinic
    Lab

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    IQVIA
    Charles River Laboratory
    ICON Plc
    Medelis, Inc.
    Medpace Holdings, Inc.
    PAREXEL International
    Pharmaceutical Product Development, LLC
    Pivotal
    PRA Health Sciences
    Syneos Health

    Buy now